Cargando…

Correction of metabolic acidosis improves insulin resistance in chronic kidney disease

BACKGROUND: Correction of metabolic acidosis (MA) with nutritional therapy or bicarbonate administration is widely used in chronic kidney disease (CKD) patients. However, it is unknown whether these interventions reduce insulin resistance (IR) in diabetic patients with CKD. We sought to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bellasi, Antonio, Di Micco, Lucia, Santoro, Domenico, Marzocco, Stefania, De Simone, Emanuele, Cozzolino, Mario, Di Lullo, Luca, Guastaferro, Pasquale, Di Iorio, Biagio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075179/ https://www.ncbi.nlm.nih.gov/pubmed/27770799 http://dx.doi.org/10.1186/s12882-016-0372-x

Ejemplares similares

Correction to: Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study
por: Di Iorio, Biagio R., et al.
Publicado: (2020)

Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study
por: Di Iorio, Biagio R., et al.
Publicado: (2019)

Very Low Protein Diet for Patients with Chronic Kidney Disease: Recent Insights
por: Di Micco, Lucia, et al.
Publicado: (2019)

Very Low-Protein Diet (VLPD) Reduces Metabolic Acidosis in Subjects with Chronic Kidney Disease: The “Nutritional Light Signal” of the Renal Acid Load
por: Di Iorio, Biagio Raffaele, et al.
Publicado: (2017)

Chronic Kidney Disease: The Silent Epidemy
por: Bellasi, Antonio, et al.
Publicado: (2019)

Fractional Excretion of Phosphate (FeP) Is Associated with End-Stage Renal Disease Patients with CKD 3b and 5
por: Bellasi, Antonio, et al.
Publicado: (2019)

Vascular Calcification Progression Modulates the Risk Associated with Vascular Calcification Burden in Incident to Dialysis Patients
por: Bellasi, Antonio, et al.
Publicado: (2021)

Kidney Disease in HIV Infection
por: Alfano, Gaetano, et al.
Publicado: (2019)

Predictive Value of Measures of Vascular Calcification Burden and Progression for Risk of Death in Incident to Dialysis Patients
por: Bellasi, Antonio, et al.
Publicado: (2021)

Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study)
por: Di Iorio, Biagio Raffaele, et al.
Publicado: (2019)

Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation
por: Magliocca, Giorgia, et al.
Publicado: (2022)

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide
por: Cozzolino, Mario, et al.
Publicado: (2017)

Phosphate Metabolism Modulation in Chronic Kidney Disease: When, How and to What Extent?
por: Bellasi, Antonio, et al.
Publicado: (2014)

Long-term L-Carnitine Administration reduces Erythropoietin Resistance in Chronic Hemodialysis Patients with Thalassemia Minor
por: Di Iorio, Biagio R., et al.
Publicado: (2007)

Pathophysiology of the cardio-renal syndromes types 1–5: An uptodate
por: Di Lullo, L., et al.
Publicado: (2017)

Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
por: Magnocavallo, Michele, et al.
Publicado: (2020)

Supplementation of Short-Chain Fatty Acid, Sodium Propionate, in Patients on Maintenance Hemodialysis: Beneficial Effects on Inflammatory Parameters and Gut-Derived Uremic Toxins, A Pilot Study (PLAN Study)
por: Marzocco, Stefania, et al.
Publicado: (2018)

Inflammation and Oxidative Stress in Chronic Kidney Disease—Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites
por: Rapa, Shara Francesca, et al.
Publicado: (2019)

QT interval in CKD and haemodialysis patients
por: Di Iorio, Biagio, et al.
Publicado: (2013)

Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease
por: Di Lullo, Luca, et al.
Publicado: (2015)

Arterial function and cardiovascular risk in dialysis
por: Iorio, Biagio R Di, et al.
Publicado: (2015)

Correction: Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”. J. Clin. Med. 2019, 8, 1066
por: Russo, Domenico, et al.
Publicado: (2020)

Ketoanalogs’ Effects on Intestinal Microbiota Modulation and Uremic Toxins Serum Levels in Chronic Kidney Disease (Medika2 Study)
por: Rocchetti, Maria Teresa, et al.
Publicado: (2021)

Finerenone: Questions and Answers—The Four Fundamental Arguments on the New-Born Promising Non-Steroidal Mineralocorticoid Receptor Antagonist
por: Di Lullo, Luca, et al.
Publicado: (2023)

Ultrapure dialysis water obtained with additional ultrafilter may reduce inflammation in patients on hemodialysis
por: Di Iorio, Biagio, et al.
Publicado: (2017)

Low-grade metabolic acidosis as a driver of insulin resistance
por: DiNicolantonio, James J, et al.
Publicado: (2021)

Low-protein diets for chronic kidney disease patients: the Italian experience
por: Bellizzi, Vincenzo, et al.
Publicado: (2016)

Cinacalcet: the chemical parathyroidectomy?
por: Bellasi, Antonio, et al.
Publicado: (2013)

Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”
por: Russo, Domenico, et al.
Publicado: (2019)

Diagnostic Workup for Disorders of Bone and Mineral Metabolism in Patients with Chronic Kidney Disease in the Era of KDIGO Guidelines
por: Morrone, Luigi Francesco, et al.
Publicado: (2011)

Mineral and Electrolyte Disorders With SGLT2i Therapy
por: Cianciolo, Giuseppe, et al.
Publicado: (2019)

The “FIFTY SHADOWS” of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease
por: Romero-González, Gregorio, et al.
Publicado: (2022)

Nutritional Approaches for the Management of Metabolic Acidosis in Chronic Kidney Disease
por: Noce, Annalisa, et al.
Publicado: (2021)

Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis
por: Garibotto, Giacomo, et al.
Publicado: (2015)

Associations of Calcium from Food Sources versus Phosphate Binders with Serum Calcium and FGF23 in Hemodialysis Patients
por: Mahdavi, Sara, et al.
Publicado: (2019)

Lanthanum carbonate is not associated with QT interval modification in hemodialysis patients
por: Di Iorio, Biagio, et al.
Publicado: (2010)

Epidemiology of low-proteinuric chronic kidney disease in renal clinics
por: De Nicola, Luca, et al.
Publicado: (2017)

Metformin: When Should We Fear Lactic Acidosis?
por: Di Mauro, Stefania, et al.
Publicado: (2022)

Effect of Indoxyl Sulfate on the Repair and Intactness of Intestinal Epithelial Cells: Role of Reactive Oxygen Species’ Release
por: Adesso, Simona, et al.
Publicado: (2019)

Pro-Inflammatory Effects of Indoxyl Sulfate in Mice: Impairment of Intestinal Homeostasis and Immune Response
por: Rapa, Shara Francesca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hnac130705gubkpfi7sahhsqef